Conditions: Hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 324
Healthy volunteers: no

Brief summary:
The primary objectives of this trial is to demonstrate that the fixed-dose combination of telmisartan 80mg plus amlodipine 5mg (T80/A5) is superior to amlodipine 5mg (A5) in reducing seated trough diastolic blood pressure (DBP) at 8 weeks.

Detailed description:

Arms:
arm 1: combination therapy arm 2: Monotherapy

Interventions: intervention 1: Telmisartan80mg+Amlodipine5mg intervention 2: amlodipine 5mg intervention 3: Telmisartan80mg+Amlodipine 5mg
Intervention descriptions: intervention 1: combination therapy intervention 2: monotherapy intervention 3: combination therapy

Protocol document: